EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism After Pregnancy: Pooled Analysis of Data from Two Randomized Controlled Trials

Michael W Varner, Lisa Mele, Brian M Casey, Alan M Peaceman, Uma M Reddy, Ronald J Wapner, John M Thorp, George R Saade, Alan T N Tita, Dwight J Rouse, Baha M Sibai, Maged M Costantine und 3 weitere

Thyroid® · 2024-09 · 34 (9) · 1171-1176

DOI: 10.1089/thy.2023.0616 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Thyroid®, online erschienen am 17.09.2024. Verfasst von Michael W Varner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Disease Progression, Hypothyroidism, Pregnancy Complications, Thyrotropin. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To examine the incidence of overt hypothyroidism 1 and 5 years after pregnancies where screening before 21 weeks identified subclinical hypothyroidism (SH) or hypothyroxinemia (HT).

Methods

Secondary analysis of two multicenter treatment trials for either SH or HT diagnosed between 8 and 20 weeks gestation. Current analyses focus only on individuals randomized to the placebo groups in the two parallel studies. SH was diagnosed with thyrotropin (TSH) ≥4.0 mU/L and normal free T4 (fT4) (0.86–1.9 ng/dL). HT was diagnosed with normal TSH (0.08–3.99 mU/L) but fT4 50 IU/mL in participants with SH was associated with higher rates of hypothyroidism at year 1 (26.7% vs. 6.5%, odds ratio [OR] = 5.3 [confidence interval (CI) 2.6–10.7]) and year 5 (30.5% vs. 7.5%, OR = 5.4 [CI: 2.8–10.6]) compared with those with TPO levels ≤50 IU/mL. For participants with HT, no differences in overt hypothyroidism were seen at 1 year related to baseline TPO level >50 IU/mL (1/10 (10%) vs. 6/218 (2.8%), OR = 3.9 [CI: 0.43–36.1]), but more participants with TPO levels >50 IU/mL developed hypothyroidism by year 5 (2/10 (20%) vs. 4/218 (1.8%), OR = 13.4 [CI: 2.1–84.1]).

Conclusion

SH is associated with higher rates of overt hypothyroidism or thyroid replacement therapy within 5 years of delivery than is HT when these conditions are diagnosed in the first half of pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease ProgressionHypothyroidismPregnancy ComplicationsThyrotropinThyroxineAdultFemaleHumansPregnancyIncidenceIodide PeroxidaseThyroid Function Tests

Stichwörter der Autor:innen

pregnancythyroid and pregnancythyroid epidemiology

Substanzen

Iodide PeroxidaseThyrotropinThyroxine

Autor:innen und Institutionen

  • Departments of Obstetrics and Gynecology, University of Utah Health Sciences Center, Salt Lake City, Utah, USA.
  • Departments of Obstetrics and Gynecology, The George Washington University Biostatistics Center, Washington, District of Columbia, USA.
  • Departments of Obstetrics and Gynecology, University of Texas - Southwestern, Dallas, Texas, USA.
  • Departments of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, USA.
  • Departments of Obstetrics and Gynecology, The Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
  • Departments of Obstetrics and Gynecology, Columbia University, New York, New York, USA.

Förderung

  • NICHD NIH HHS

Zitieren

APA

Varner, M. W., Mele, L., Casey, B. M., Peaceman, A. M., Reddy, U. M., Wapner, R. J., Thorp, J. M., Saade, G. R., Tita, A. T. N., Rouse, D. J., Sibai, B. M., Costantine, M. M., Mercer, B. M., Caritis, S. N., & Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD, USA (2024). Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism After Pregnancy: Pooled Analysis of Data from Two Randomized Controlled Trials. Thyroid®, 34(9), 1171-1176. https://doi.org/10.1089/thy.2023.0616

Vancouver

Varner MW, Mele L, Casey BM, Peaceman AM, Reddy UM, Wapner RJ, et al. Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism After Pregnancy: Pooled Analysis of Data from Two Randomized Controlled Trials. Thyroid®. 2024;34(9):1171-1176. doi:10.1089/thy.2023.0616

BibTeX
@article{Varner2024,
  author = {Varner, Michael W and Mele, Lisa and Casey, Brian M and Peaceman, Alan M and Reddy, Uma M and Wapner, Ronald J and Thorp, John M and Saade, George R and Tita, Alan T N and Rouse, Dwight J and Sibai, Baha M and Costantine, Maged M and Mercer, Brian M and Caritis, Steve N and Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD, USA, Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network, Bethesda, MD, USA},
  title = {Progression of Gestational Subclinical Hypothyroidism and Hypothyroxinemia to Overt Hypothyroidism After Pregnancy: Pooled Analysis of Data from Two Randomized Controlled Trials},
  journal = {Thyroid®},
  year = {2024},
  volume = {34},
  number = {9},
  pages = {1171--1176},
  doi = {10.1089/thy.2023.0616}
}
Kostenlos starten →